GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway

GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway

Gemcitabine-based chemotherapy is the first-line treatment for pancreatic cancer. However, chemoresistance is a major obstacle to drug efficacy, leading to poor prognosis. Little progress has been achieved although multiple mechanisms are investigated. Therefore, effective strategies are urgently ne...

Full description

Bibliographic Details
Main Authors:	Zhenyu Chang, Yanan Zhang, Jie Liu, Chengjian Guan, Xinjin Gu, Zelong Yang, Qinong Ye, Lihua Ding, Rong Liu
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2019/9474273

Similar Items

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
by: Yunjiang Zhou, et al.
Published: (2019-04-01)

Transduction of TAT/PTD Antiapoptotic Fusion Proteins in Pancreatic Islets
by: Jennifer Embury, et al.
Published: (2001-01-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
by: Ru Chen, et al.
Published: (2017-08-01)

Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
by: Yukai Xiang, et al.
Published: (2018-01-01)

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer
by: Wenbin Li, et al.
Published: (2020-03-01)

Mechanisms of gemcitabine resistance in pancreatic cancer
by: Melling, J.
Published: (2017)

Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
by: Lusheng Wei, et al.
Published: (2021-03-01)

The Neuroprotective Effects of Carvacrol on Ethanol-Induced Hippocampal Neurons Impairment via the Antioxidative and Antiapoptotic Pathways
by: Peng Wang, et al.
Published: (2017-01-01)

miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis
by: Fang Ran, et al.
Published: (2021-01-01)

Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina
by: Manabe, Shinichi
Published: (2011)

Epibrassinolide Promotes the Apoptotic Potential of Gemcitabine in Pancreatic Cancer Cells
by: Fadina Kuryayeva, et al.
Published: (2019-12-01)

An Antiapoptotic Neuroprotective Role for Neuroglobin
by: Thomas Brittain, et al.
Published: (2010-05-01)

Antiapoptotic Effects of EGb 761
by: Norma Serrano-García, et al.
Published: (2013-01-01)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Viruses with deletions in antiapoptotic genes as potential oncolytic agents
by: Liu, Dajiang
Published: (2003)

Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
by: Wei-Tian Wei, Hui Chen, Zhao-Hong Wang, Zhong-Lin Ni, Hai-Bin Liu, Hong-Fei Tong, Hong-Chun Guo, Dian-Lei Liu, Sheng-Zhang Lin
Published: (2012-01-01)

Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer
by: Wenjie Su, et al.
Published: (2021-03-01)

Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine
by: Shangnan Dai, et al.
Published: (2020-01-01)

Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine
by: Hua Li, et al.
Published: (2017-06-01)

GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression
by: Weiliang Jiang, et al.
Published: (2021-04-01)

Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
by: Manoj Amrutkar, et al.
Published: (2019-06-01)

Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
by: Sheng Wang, et al.
Published: (2021-03-01)

ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway
by: Chunmei Yang, et al.
Published: (2021-01-01)

Antiapoptotic Role for Lifeguard in T Cell Mediated Immune Response.
by: Tatiana Hurtado de Mendoza, et al.
Published: (2015-01-01)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
by: Amber Blaauboer, et al.
Published: (2020-09-01)

Predictive modeling of in vivo response to gemcitabine in pancreatic cancer.
by: James J Lee, et al.
Published: (2013-01-01)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl Daniel, et al.
Published: (2012-03-01)

Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
by: Bugde, Piyush
Published: (2019)

BI 6727 and gemcitabine combination therapy in pancreatic cancer
by: Jones, O. P.
Published: (2018)

Molecular mechanisms of acquired gemcitabine resistance in pancreatic cancer
by: Qin, Li
Published: (2015)

Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer
by: Leblond Lorraine, et al.
Published: (2007-07-01)

Overexpression of GATA4 enhances the antiapoptotic effect of exosomes secreted from cardiac colony-forming unit fibroblasts via miRNA221-mediated targeting of the PTEN/PI3K/AKT signaling pathway
by: Chunshu Hao, et al.
Published: (2020-06-01)

Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway
by: Changjie Lou, et al.
Published: (2019-01-01)

CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species
by: Zhiping Fu, et al.
Published: (2018-04-01)

Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
by: Zheng Zhang, et al.
Published: (2021-08-01)

Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma.
by: Lisa Leung, et al.
Published: (2012-01-01)

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
by: Moehler Markus, et al.
Published: (2011-08-01)

Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody
by: Charles L Howe, et al.
Published: (2004-02-01)

GATA4 inhibits cell differentiation and proliferation in pancreatic cancer.
by: Yan Gong, et al.
Published: (2018-01-01)